Plus Therapeutics, Inc.
PSTV
$5.50
-$0.03-0.54%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.93M | -22.39M | -20.58M | -19.03M | -27.12M |
| Total Depreciation and Amortization | 408.00K | 480.00K | 683.00K | 805.00K | 898.00K |
| Total Amortization of Deferred Charges | -- | -- | -20.00K | -20.00K | -16.00K |
| Total Other Non-Cash Items | -4.30M | 7.17M | 6.49M | 5.11M | 10.64M |
| Change in Net Operating Assets | -5.02M | -6.04M | -2.31M | -3.72M | 3.39M |
| Cash from Operations | -20.84M | -20.78M | -15.73M | -16.86M | -12.21M |
| Capital Expenditure | -882.00K | -67.00K | -48.00K | -35.00K | -109.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 30.00K | 30.00K | 30.00K | 30.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.06M | -817.00K | 305.00K | -1.01M | -110.00K |
| Cash from Investing | -12.95M | -854.00K | 287.00K | -1.02M | -189.00K |
| Total Debt Issued | 1.75M | 4.49M | 3.74M | 3.74M | 7.03M |
| Total Debt Repaid | -1.10M | -7.00M | -7.00M | -7.00M | -10.59M |
| Issuance of Common Stock | 22.88M | 38.54M | 35.54M | 18.68M | 22.97M |
| Repurchase of Common Stock | -- | -- | 0.00 | -45.00K | -45.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.41M | -5.72M | -4.77M | -175.00K | 0.00 |
| Cash from Financing | 26.94M | 30.31M | 27.51M | 15.20M | 19.37M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.85M | 8.68M | 12.07M | -2.68M | 6.97M |